EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Kibra knockdown inhibits the aberrant Hippo pathway, suppresses renal cyst formation and ameliorates renal fibrosis in nphp1 KO mice

Yichen Yang iD, Zhihe Xue, Jiayong Lai, Jinglan Zhang, Changmiao Pang, Jinglin Zhong, Zhanpeng Kuang, Baojuan Zou, Yaqing Liu, Liangzhong Sun

Clinical and Translational Medicine · 2025

DOI: 10.1002/ctm2.70245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2025. Verfasst von Yichen Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Kidney Diseases, Cystic, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Nephronophthisis (NPH) is an autosomal recessive interstitial cystic kidney disease, which is the most common genetic cause of end‐stage renal disease (ESRD) in childhood. The Hippo pathway is regulated by the cilium and has been suggested to be linked to NPH. The aim of the study was to investigate the involvement of Hippo pathway in the pathogenesis of nphp1 defect‐associated NPH (NPH1).

Method

Nphp1 knockout ( nphp1 KO ) Madin‐Darby Canine Kidney (MDCK) cells and nphp1 KO C57BL/6J mice were generated via CRISPR gene editing strategy. The siRNAs targeting Kibra , MST1 and LATS1 were designed. An AAV9 vector was designed for Kibra knockdown. The expression and phosphorylation of core Hippo pathway molecules were evaluated. Pathological renal changes were evaluated via light microscopy respectively with haematoxylin–eosin and Masson staining.

Results

In nphp1 KO MDCK cells, nphp1 KO mice and NPH1 patients’ kidneys, Kibra, p‐MST1/2, p‐LATS and p‐YAP exhibited a notable increase in levels, with an even greater elevation observed in renal cyst cells, indicating the Hippo pathway activated in these nphp1 ‐deficient contexts. Nphp1 re‐expression reversed the Hippo pathway activation in cells, indicating that the Hippo pathway activation is related to nphp1 deficiency in vitro. Meanwhile, in vitro, MST1 knockdown downregulated LATS1 and YAP phosphorylation, LATS1 knockdown downregulated YAP phosphorylation, suggesting the activation of the canonical Hippo pathway in nphp1 ‐deficient contexts. Knockdown of the upstream regulator Kibra inhibited the Hippo pathway activation in both nphp1 KO MDCK cells and mice. Following Kibra knockdown, the organisation of nphp1 KO MDCK cells became more compact, the intensity of the actin fibres increased. Besides, decreased renal fibrosis and cyst formation were observed in nphp1 KO mice.

Conclusions

The canonical Hippo pathway is aberrantly activated in nphp1 ‐deficient conditions. Kibra may serve as a crucial upstream regulator of nphp1 deficiency‐related Hippo pathway activation. Kibra upregulation and activation of the Hippo pathway are involved in the pathogenesis of NPH1. Key Points Canonical Hippo pathway activated in nphp1 ‐deficient disease models and patients. Kibra was a key upstream molecule in regulating the activation of canonical Hippo pathway in nphp1 ‐deficient disease models and patients and closely related to renal cyst formation and fibrosis in nphp1 KO mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney Diseases, CysticIntracellular Signaling Peptides and ProteinsAnimalsMiceMice, KnockoutHippo Signaling PathwayDogsFibrosisProtein Serine-Threonine KinasesKidneyMice, Inbred C57BLHumansMadin Darby Canine Kidney CellsSignal TransductionDisease Models, Animal

Stichwörter der Autor:innen

Hippo pathwayKibranephronophthisisnphp1renal cyst

Substanzen

Protein Serine-Threonine KinasesIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Department of Pediatrics, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, China.
  • Department of Pediatrics, The First Affiliated Hospital, Gannan Medical University, Ganzhou, China.

ORCID-Profile: Yichen Yang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Yang, Y., Xue, Z., Lai, J., Zhang, J., Pang, C., Zhong, J., Kuang, Z., Zou, B., Liu, Y., & Sun, L. (2025). Kibra knockdown inhibits the aberrant Hippo pathway, suppresses renal cyst formation and ameliorates renal fibrosis in nphp1 KO mice. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70245

Vancouver

Yang Y, Xue Z, Lai J, Zhang J, Pang C, Zhong J, et al. Kibra knockdown inhibits the aberrant Hippo pathway, suppresses renal cyst formation and ameliorates renal fibrosis in nphp1 KO mice. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70245

BibTeX
@article{Yang2025,
  author = {Yang, Yichen and Xue, Zhihe and Lai, Jiayong and Zhang, Jinglan and Pang, Changmiao and Zhong, Jinglin and Kuang, Zhanpeng and Zou, Baojuan and Liu, Yaqing and Sun, Liangzhong},
  title = {Kibra knockdown inhibits the aberrant Hippo pathway, suppresses renal cyst formation and ameliorates renal fibrosis in nphp1 KO mice},
  journal = {Clinical and Translational Medicine},
  year = {2025},
  doi = {10.1002/ctm2.70245}
}
Kostenlos starten →